The emerging roles of TCF4 in disease and development.

Genome-wide association studies have identified common variants in transcription factor 4 (TCF4) as susceptibility loci for schizophrenia, Fuchs' endothelial corneal dystrophy, and primary sclerosing cholangitis. By contrast, rare TCF4 mutations cause Pitt-Hopkins syndrome, a disorder characterized by intellectual disability and developmental delay, and have also been described in patients with other neurodevelopmental disorders. TCF4 therefore sits at the nexus between common and rare disorders. TCF4 interacts with other basic helix-loop-helix proteins, forming transcriptional networks that regulate the differentiation of several distinct cell types. Here, we review the role of TCF4 in these seemingly diverse disorders and discuss recent data implicating TCF4 as an important regulator of neurodevelopment and epithelial-mesenchymal transition.

[1]  François Guillemot,et al.  Proneural genes and the specification of neural cell types , 2002, Nature Reviews Neuroscience.

[2]  S. Wijmenga,et al.  Backbone dynamics of a symmetric calmodulin dimer in complex with the calmodulin-binding domain of the basic-helix-loop-helix transcription factor SEF2-1/E2-2: a highly dynamic complex. , 2005, Biophysical journal.

[3]  M. Rossner,et al.  Cognitive and Sensorimotor Gating Impairments in Transgenic Mice Overexpressing the Schizophrenia Susceptibility Gene Tcf4 in the Brain , 2010, Biological Psychiatry.

[4]  C. Murre Helix-loop-helix proteins and lymphocyte development , 2005, Nature Immunology.

[5]  S. Yoon,et al.  Isolation of two E-box binding factors that interact with the rat tyrosine hydroxylase enhancer. , 1994, The Journal of biological chemistry.

[6]  Nathalie Boddaert,et al.  Mutations in TCF4, encoding a class I basic helix-loop-helix transcription factor, are responsible for Pitt-Hopkins syndrome, a severe epileptic encephalopathy associated with autonomic dysfunction. , 2007, American journal of human genetics.

[7]  D. Baltimore,et al.  Mutations that disrupt DNA binding and dimer formation in the E47 helix-loop-helix protein map to distinct domains. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[8]  T. Grundström,et al.  Helix-loop-helix transcriptional activators bind to a sequence in glucocorticoid response elements of retrovirus enhancers , 1991, Journal of virology.

[9]  M. Greenberg,et al.  Coupling of cell migration with neurogenesis by proneural bHLH factors , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[10]  R. Kageyama,et al.  Molecular characterization of a rat negative regulator with a basic helix-loop-helix structure predominantly expressed in the developing nervous system. , 1992, The Journal of biological chemistry.

[11]  M. Rossner,et al.  Transcription factor 4 (TCF4) and schizophrenia: integrating the animal and the human perspective , 2014, Cellular and Molecular Life Sciences.

[12]  Raghu Kalluri,et al.  The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.

[13]  Juliane Hoyer,et al.  Haploinsufficiency of TCF4 causes syndromal mental retardation with intermittent hyperventilation (Pitt-Hopkins syndrome). , 2007, American journal of human genetics.

[14]  A. Hoischen,et al.  Severe mental retardation with breathing abnormalities (Pitt-Hopkins syndrome) is caused by haploinsufficiency of the neuronal bHLH transcription factor TCF4. , 2007, Human molecular genetics.

[15]  T. Grundström,et al.  Calcium regulation of myogenesis by differential calmodulin inhibition of basic helix-loop-helix transcription factors. , 2008, Molecular biology of the cell.

[16]  H. Weintraub,et al.  B-lymphocyte development is regulated by the combined dosage of three basic helix-loop-helix genes, E2A, E2-2, and HEB , 1996, Molecular and cellular biology.

[17]  J. Rüschoff,et al.  The helix‐loop‐helix transcription factor SEF‐2 regulates the activity of a novel initiator element in the promoter of the human somatostatin receptor II gene. , 1996, The EMBO journal.

[18]  A. Goldrath,et al.  The signal transducers STAT5 and STAT3 control expression of Id2 and E2-2 during dendritic cell development. , 2012, Blood.

[19]  T. Grundström,et al.  The basic helix‐loop‐helix transcription factor E2–2 is involved in T lymphocyte development , 2000, European journal of immunology.

[20]  N. Katsanis,et al.  Mutations in AGBL1 cause dominant late-onset Fuchs corneal dystrophy and alter protein-protein interaction with TCF4. , 2013, American journal of human genetics.

[21]  D. Rujescu,et al.  A comprehensive family-based replication study of schizophrenia genes. , 2013, JAMA psychiatry.

[22]  G. Rouleau,et al.  Parent–child exome sequencing identifiesa de novo truncating mutation in TCF4 in non‐syndromic intellectual disability , 2013, Clinical genetics.

[23]  S. Phillips Built by association: structure and function of helix-loop-helix DNA-binding proteins. , 1994, Structure.

[24]  Richard A. Currie,et al.  E2A-PBX1 Interacts Directly with the KIX Domain of CBP/p300 in the Induction of Proliferation in Primary Hematopoietic Cells* , 2004, Journal of Biological Chemistry.

[25]  Jean Paul Thiery,et al.  Epithelial-mesenchymal transitions: insights from development , 2012, Development.

[26]  K. Lewis,et al.  Continuous expression of the transcription factor e2-2 maintains the cell fate of mature plasmacytoid dendritic cells. , 2010, Immunity.

[27]  T. Pastinen Genome-wide allele-specific analysis: insights into regulatory variation , 2010, Nature Reviews Genetics.

[28]  D. Rujescu,et al.  Novel Schizophrenia Risk Gene TCF4 Influences Verbal Learning and Memory Functioning in Schizophrenia Patients , 2011, Neuropsychobiology.

[29]  S. K. Ray,et al.  A Splice Variant of E2–2 Basic Helix-Loop-Helix Protein Represses the Brain-specific Fibroblast Growth Factor 1 Promoter through the Binding to an Imperfect E-box* , 1998, The Journal of Biological Chemistry.

[30]  C. Gieger,et al.  Genome‐wide association analysis in Primary sclerosing cholangitis and ulcerative colitis identifies risk loci at GPR35 and TCF4 , 2013, Hepatology.

[31]  David A Lewis,et al.  Schizophrenia as a disorder of neurodevelopment. , 2002, Annual review of neuroscience.

[32]  S. Harrison,et al.  Crystal structure of transcription factor E47: E-box recognition by a basic region helix-loop-helix dimer. , 1994, Genes & development.

[33]  Antonella Longo,et al.  Crystal structure of E47-NeuroD1/beta2 bHLH domain-DNA complex: heterodimer selectivity and DNA recognition. , 2008, Biochemistry.

[34]  Pall I. Olason,et al.  Common variants conferring risk of schizophrenia , 2009, Nature.

[35]  D. Rujescu,et al.  Neurexin 1 (NRXN1) deletions in schizophrenia. , 2009, Schizophrenia bulletin.

[36]  M. Forrest,et al.  Knockdown of Human TCF4 Affects Multiple Signaling Pathways Involved in Cell Survival, Epithelial to Mesenchymal Transition and Neuronal Differentiation , 2013, PloS one.

[37]  C. Thaller,et al.  The E-protein Tcf4 interacts with Math1 to regulate differentiation of a specific subset of neuronal progenitors , 2007, Proceedings of the National Academy of Sciences.

[38]  B. Kee E and ID proteins branch out , 2009, Nature Reviews Immunology.

[39]  Annette Schenck,et al.  CNTNAP2 and NRXN1 are mutated in autosomal-recessive Pitt-Hopkins-like mental retardation and determine the level of a common synaptic protein in Drosophila. , 2009, American journal of human genetics.

[40]  S. Rose-John,et al.  Transcriptional profiling identifies Id2 function in dendritic cell development , 2003, Nature Immunology.

[41]  J. Sebat,et al.  Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene. , 2008, American journal of human genetics.

[42]  A. Munnich,et al.  Mutational, functional, and expression studies of the TCF4 gene in Pitt‐Hopkins syndrome , 2009, Human mutation.

[43]  Jürgen Gallinat,et al.  Schizophrenia risk polymorphisms in the TCF4 gene interact with smoking in the modulation of auditory sensory gating , 2012, Proceedings of the National Academy of Sciences.

[44]  J. Olson,et al.  Generation of neurons by transient expression of neural bHLH proteins in mammalian cells. , 2000, Development.

[45]  M. Frotscher,et al.  Neuronal Basic Helix-Loop-Helix Proteins (NEX and BETA2/Neuro D) Regulate Terminal Granule Cell Differentiation in the Hippocampus , 2000, The Journal of Neuroscience.

[46]  S. Wijmenga,et al.  A novel target recognition revealed by calmodulin in complex with the basic helix–loop–helix transcription factor SEF2‐1/E2‐2 , 2001, Protein science : a publication of the Protein Society.

[47]  R. Shigemoto,et al.  Two mammalian helix-loop-helix factors structurally related to Drosophila hairy and Enhancer of split. , 1992, Genes & development.

[48]  Patrick F. Sullivan,et al.  Genetic architectures of psychiatric disorders: the emerging picture and its implications , 2012, Nature Reviews Genetics.

[49]  M. Caudy,et al.  Hairy function as a DNA-binding helix-loop-helix repressor of Drosophila sensory organ formation. , 1994, Genes & development.

[50]  S. Berger,et al.  A conserved motif present in a class of helix-loop-helix proteins activates transcription by direct recruitment of the SAGA complex. , 1999, Molecular cell.

[51]  F. Guillemot,et al.  Old and new functions of proneural factors revealed by the genome-wide characterization of their transcriptional targets , 2011, Cell Cycle.

[52]  D. Horn,et al.  Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study , 2012, The Lancet.

[53]  V. Pascual,et al.  Type I interferon in systemic lupus erythematosus and other autoimmune diseases. , 2006, Immunity.

[54]  F. Portillo,et al.  An emerging role for class I bHLH E2-2 proteins in EMT regulation and tumor progression , 2010, Cell adhesion & migration.

[55]  S. Briggs,et al.  Biochemical and Phosphoproteomic Analysis of the Helix-Loop-Helix Protein E47 , 2012, Molecular and Cellular Biology.

[56]  Gema Moreno-Bueno,et al.  Genetic profiling of epithelial cells expressing E-cadherin repressors reveals a distinct role for Snail, Slug, and E47 factors in epithelial-mesenchymal transition. , 2006, Cancer research.

[57]  S. Djurovic,et al.  TCF4 sequence variants and mRNA levels are associated with neurodevelopmental characteristics in psychotic disorders , 2012, Translational Psychiatry.

[58]  Y. Jan,et al.  Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence , 1989, Cell.

[59]  Federica Buonocore,et al.  Effects of cis-regulatory variation differ across regions of the adult human brain. , 2010, Human molecular genetics.

[60]  M. Forrest,et al.  Functional analysis of TCF4 missense mutations that cause Pitt–Hopkins syndrome , 2012, Human mutation.

[61]  M. Owen,et al.  Association between TCF4 and schizophrenia does not exert its effect by common nonsynonymous variation or by influencing cis‐acting regulation of mRNA expression in adult human brain , 2011, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[62]  David Baltimore,et al.  A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins , 1989, Cell.

[63]  Ryoichiro Kageyama,et al.  The Hes gene family: repressors and oscillators that orchestrate embryogenesis , 2007, Development.

[64]  C. Xing,et al.  Association and familial segregation of CTG18.1 trinucleotide repeat expansion of TCF4 gene in Fuchs' endothelial corneal dystrophy. , 2014, Investigative ophthalmology & visual science.

[65]  M. Nieto,et al.  The ins and outs of the epithelial to mesenchymal transition in health and disease. , 2011, Annual review of cell and developmental biology.

[66]  M. Owen,et al.  TCF4, schizophrenia, and Pitt-Hopkins Syndrome. , 2010, Schizophrenia bulletin.

[67]  Manfred Lehner,et al.  Transcription Factor E2-2 Is an Essential and Specific Regulator of Plasmacytoid Dendritic Cell Development , 2008, Cell.

[68]  H. Petropoulos,et al.  Analysis of the Inhibition of MyoD Activity by ITF-2B and Full-length E12/E47* , 2000, The Journal of Biological Chemistry.

[69]  M. Nieto,et al.  Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. , 2009, The Journal of clinical investigation.

[70]  T. Timmusk,et al.  Functional Diversity of Human Basic Helix-Loop-Helix Transcription Factor TCF4 Isoforms Generated by Alternative 5′ Exon Usage and Splicing , 2011, PloS one.

[71]  M. Nieto,et al.  A New Role for E12/E47 in the Repression ofE-cadherin Expression and Epithelial-Mesenchymal Transitions* , 2001, The Journal of Biological Chemistry.

[72]  R. Murray,et al.  Verbal memory deficit in patients with schizophrenia: an important future target for treatment , 2004, Expert review of neurotherapeutics.

[73]  D L Braff,et al.  Sensorimotor gating and schizophrenia. Human and animal model studies. , 1990, Archives of general psychiatry.

[74]  D. Pitt,et al.  A Syndrome of Mental Retardation, Wide Mouth and Intermittent Overbreathing , 1978, Australian paediatric journal.

[75]  D. Rujescu,et al.  The Schizophrenia Risk Allele C of the TCF4 rs9960767 Polymorphism Disrupts Sensorimotor Gating in Schizophrenia Spectrum and Healthy Volunteers , 2011, The Journal of Neuroscience.

[76]  N. Joyce,et al.  Increased clusterin expression in Fuchs' endothelial dystrophy. , 2008, Investigative ophthalmology & visual science.

[77]  V. Hearing,et al.  Involvement of ITF2 in the Transcriptional Regulation of Melanogenic Genes* , 2001, The Journal of Biological Chemistry.

[78]  Toshiro K. Ohsumi,et al.  Sequencing Chromosomal Abnormalities Reveals Neurodevelopmental Loci that Confer Risk across Diagnostic Boundaries , 2012, Cell.

[79]  M. Hill,et al.  Evidence that schizophrenia risk variation in the ZNF804A gene exerts its effects during fetal brain development. , 2012, The American journal of psychiatry.

[80]  S. Iyengar,et al.  Differing Roles for TCF4 and COL8A2 in Central Corneal Thickness and Fuchs Endothelial Corneal Dystrophy , 2012, PloS one.

[81]  T. Kadesch,et al.  Two distinct transcription factors that bind the immunoglobulin enhancer microE5/kappa 2 motif. , 1990, Science.

[82]  M. Götz,et al.  Developmental cell biology: The cell biology of neurogenesis , 2005, Nature Reviews Molecular Cell Biology.

[83]  Brian T. Chait,et al.  E Protein Silencing by the Leukemogenic AML1-ETO Fusion Protein , 2004, Science.

[84]  Harold Weintraub,et al.  The protein Id: A negative regulator of helix-loop-helix DNA binding proteins , 1990, Cell.

[85]  A. Jarman,et al.  Context dependence of proneural bHLH proteins. , 2008, Current opinion in genetics & development.

[86]  M. Fraga,et al.  The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors , 2003, Journal of Cell Science.

[87]  B. Reizis Regulation of plasmacytoid dendritic cell development. , 2010, Current opinion in immunology.

[88]  V. Calhoun,et al.  Potential Impact of miR-137 and Its Targets in Schizophrenia , 2013, Front. Genet..

[89]  U. Jurkunas,et al.  Molecular bases of corneal endothelial dystrophies. , 2012, Experimental eye research.

[90]  T. Grundström,et al.  B-cell receptor activation inhibits AID expression through calmodulin inhibition of E-proteins , 2008, Proceedings of the National Academy of Sciences.

[91]  H. Stefánsson,et al.  Common variants at VRK2 and TCF4 conferring risk of schizophrenia. , 2011, Human molecular genetics.

[92]  C. Bowlus,et al.  The immunobiology of primary sclerosing cholangitis , 2009, Seminars in Immunopathology.

[93]  L. Nguyen,et al.  Neurogenin 2 controls cortical neuron migration through regulation of Rnd2 , 2008, Nature.

[94]  Informatics,et al.  E2-2 Protein and Fuchs's Corneal Dystrophy , 2022 .

[95]  T. Grundström,et al.  Basic Helix-Loop-Helix Protein Sequences Determining Differential Inhibition by Calmodulin and S-100 Proteins* , 1997, The Journal of Biological Chemistry.

[96]  Nirubol Tosakulwong,et al.  A Common Trinucleotide Repeat Expansion within the Transcription Factor 4 (TCF4, E2-2) Gene Predicts Fuchs Corneal Dystrophy , 2012, PloS one.

[97]  Francisco Portillo,et al.  The transcription factor Snail controls epithelial–mesenchymal transitions by repressing E-cadherin expression , 2000, Nature Cell Biology.

[98]  F. Guillemot,et al.  Crucial First Steps: The Transcriptional Control of Neuron Delamination , 2012, Neuron.

[99]  M. McBurney,et al.  A Splice Variant of the ITF-2 Transcript Encodes a Transcription Factor That Inhibits MyoD Activity (*) , 1996, The Journal of Biological Chemistry.

[100]  Judy H. Cho,et al.  Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis , 2013, Nature Genetics.

[101]  T. Timmusk,et al.  Pitt-Hopkins syndrome-associated mutations in TCF4 lead to variable impairment of the transcription factor function ranging from hypomorphic to dominant-negative effects. , 2012, Human molecular genetics.

[102]  A. Iavarone,et al.  ID proteins as targets in cancer and tools in neurobiology. , 2006, Trends in molecular medicine.

[103]  C. Murre,et al.  The role of E-proteins in B- and T-lymphocyte development. , 1998, Seminars in immunology.

[104]  Anders D. Børglum,et al.  Genome-wide association study identifies five new schizophrenia loci , 2011, Nature Genetics.

[105]  N. Boutros,et al.  P50, N100, and P200 sensory gating: relationships with behavioral inhibition, attention, and working memory. , 2009, Psychophysiology.

[106]  F. Portillo,et al.  The class I bHLH factors E2-2A and E2-2B regulate EMT , 2009, Journal of Cell Science.

[107]  Magnus Holm,et al.  Calcium/calmodulin inhibition of basic-helix-loop-helix transcription factor domains , 1994, Nature.

[108]  Marzena Wojciechowska,et al.  Cellular toxicity of expanded RNA repeats: focus on RNA foci , 2011, Human molecular genetics.

[109]  A. Goldfarb,et al.  Identification of a Highly Conserved Module in E Proteins Required for in Vivo Helix-loop-helix Dimerization* , 1998, The Journal of Biological Chemistry.

[110]  P. Visscher,et al.  Common polygenic variation contributes to risk of schizophrenia and bipolar disorder , 2009, Nature.

[111]  D. Clair,et al.  A survey of rare coding variants in candidate genes in schizophrenia by deep sequencing , 2013, Molecular Psychiatry.

[112]  N. Wu,et al.  A negative regulatory element-dependent inhibitory role of ITF2B on IL-2 receptor α gene ☆ ☆☆ , 2005 .

[113]  C. Murre,et al.  Helix-Loop-Helix Proteins: Regulators of Transcription in Eucaryotic Organisms , 2000, Molecular and Cellular Biology.